Pathogenetic Therapy of Psoriasis by Muramyl Peptide

Overview of attention for article published in Frontiers in immunology, June 2019

Altmetric Badge

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 34,635 followers.

Pathogenetic Therapy of Psoriasis by Muramyl Peptide. https://t.co/0XTYZcDjK5

24 Oct 2020

Reply Repost Favourite

RT @FrontImmunol: New Research: Pathogenetic Therapy of Psoriasis by Muramyl Peptide: Psoriasis is a multifactorial disease with a dysregul…

21 Jun 2019

Reply Repost Favourite

New Research: Pathogenetic Therapy of Psoriasis by Muramyl Peptide: Psoriasis is a multifactorial disease with a dysregulation in immune system. The aim of this study was to survey the clinical efficacy and safety of muramyl peptide - the… https://t.co/u20

20 Jun 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.